$1.020
+0.029 (+2.87%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Lisata Therapeutics Inc (LSTA) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting LSTA is Strong sell.
Lisata Therapeutics Inc (LSTA) 20-Day simple moving average is 1.03, while Lisata Therapeutics Inc (LSTA) share price is $—, making it Sell.
Lisata Therapeutics Inc (LSTA) 60-Day simple moving average is 1.34, while Lisata Therapeutics Inc (LSTA) share price is $—, making it Sell.
Technical Analysis for LSTA
AI Technical LSTAAs of 2026-11-07, the technical board for Lisata Therapeutics Inc (LSTA) reads strong sell: 1 indicators are flashing buy, 8 are indicating sell, and 4 are neutral. Price at $1.02 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 42.456, MACD stands at -0.0773 (Sell), Stochastic %K stands at 35.5, Stochastic %D stands at 43.763 and CCI stands at -40.265.
LSTA trades below the 60-day SMA (1.34) and below the 200-day SMA (2.94). Immediate resistance sits at Classic R1 1.14, then R2 1.23. Support sits at Classic S1 0.95, then S2 0.86.
Lisata Therapeutics Inc (LSTA) Support & Resistance Level
Lisata Therapeutics Inc (LSTA) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 42.456 |
| STOCHk_14_3_3 | 35.500 |
| STOCHd_14_3_3 | 43.763 |
| CCI_20 | -40.265 |
| AO_5_34 | -0.135 |
| MOM_10 | 0.034 |
| MACD_12_26_9 | -0.077 |
Lisata Therapeutics Inc (LSTA) Relative Strength Index (RSI_14) is 42.456, creating a Neutral signal.
Lisata Therapeutics Inc (LSTA) Stochastic %K is 35.500, creating a Neutral signal.
Lisata Therapeutics Inc (LSTA) Stochastic %D is 43.763, creating a Neutral signal.
Lisata Therapeutics Inc (LSTA) CCI_20 is -40.265, creating a Neutral signal.
Lisata Therapeutics Inc (LSTA) Awesome Oscillator (AO) is -0.135, creating a Sell signal.
Lisata Therapeutics Inc (LSTA) Momentum (MOM) is 0.034, creating a Buy signal.
Lisata Therapeutics Inc (LSTA) Moving Average Convergence Divergence (MACD) is -0.077, creating a Sell signal.
Lisata Therapeutics Inc (LSTA) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.036 | Sell |
| MA_10 | 1.035 | Sell |
| MA_20 | 1.035 | Sell |
| MA_60 | 1.340 | Sell |
| MA_200 | 2.944 | Sell |
| MA_250 | 2.778 | Sell |
Lisata Therapeutics Inc (LSTA) 5-Day simple moving average is 1.036, while Lisata Therapeutics Inc (LSTA) share price is $, making it a Sell.
Lisata Therapeutics Inc (LSTA) 10-Day simple moving average is 1.035, while Lisata Therapeutics Inc (LSTA) share price is $, making it a Sell.
Lisata Therapeutics Inc (LSTA) 20-Day simple moving average is 1.035, while Lisata Therapeutics Inc (LSTA) share price is $, making it a Sell.
Lisata Therapeutics Inc (LSTA) 60-Day simple moving average is 1.340, while Lisata Therapeutics Inc (LSTA) share price is $, making it a Sell.
Lisata Therapeutics Inc (LSTA) 200-Day simple moving average is 2.944, while Lisata Therapeutics Inc (LSTA) share price is $, making it a Sell.
Lisata Therapeutics Inc (LSTA) 250-Day simple moving average is 2.778, while Lisata Therapeutics Inc (LSTA) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.